Document Type
Blog Post
Publication Date
9-16-2018
Disciplines
Nervous System Diseases
Digital USD Citation
Serbin, Kenneth P., "Roche Phase 3 clinical trial for Huntington’s disease gene-slicing drug to enroll volunteers in early 2019" (2018). At Risk for Huntington's Disease. 257.
https://digital.sandiego.edu/huntingtons/257
